“I’m here to help” – Donald Trump gets praise from $5.7 billion rich Mark Cuban for latest healthcare order

Mark Cuban is extending strong support for President Donald Trump’s recent healthcare executive order. In a surprising political alignment, Cuban praised the move as a step in the right direction toward much-needed drug reform. He called for a complete overhaul of the U.S. healthcare system, citing the high cost of prescription medications. Cuban, who has recently been in the sports headlines for his comments on the Dallas Mavericks’ surprising Luka Doncic trade, extended his support for the President of the United States in a recent post on X.

Mark Cuban who made his name known to the world for his appearance in the popular reality show, Shark Tank, is throwing his support behind President Donald Trump’s executive order on healthcare, calling it a potential game-changer for the country. The billionaire entrepreneur who boasts a stunning $5.7 billion fortune (per Forbes) believes the drug pricing reforms outlined in the order could save hundreds of billions of dollars, especially by reining in the power of pharmacy benefit managers (PBMs).
“Gotta be honest. The @realDonaldTrump EO on healthcare and in particular, drug pricing could save hundreds of billions,” the Dallas Mavericks minority owner wrote on X.

Cuban argues that formularies (the lists that determine which drugs are covered) should be removed from PBM control and placed in the hands of independent organizations with no financial incentives. “They should be focused on wellness, not on pay-for-play setups like grocery store endcaps,” he shared. He believes patients would receive better care at lower costs by ending rebates and pushing for true net pricing.
He also called for mandatory data transparency, stating that PBMs should be required to share all claims data with employers, state agencies, and drug manufacturers. Currently, manufacturers often pay 5–10% of a drug’s retail price just to access data they need to improve patient outcomes, which Cuban finds “insane.”
In addition, Cuban took aim at the so-called “specialty tier,” arguing that the term is used as a pricing gimmick. He wants the requirement to use specific pharmacies for specialty drugs removed and called for divestment from any pharmacy operations PBMs control. Independent pharmacies, he said, must be protected and fully reimbursed, especially for brand-name drugs.
Cuban also criticized confidentiality clauses that prevent companies from negotiating directly with drug manufacturers. “It’s crazy that a company can’t even speak to a manufacturer to set up a wellness plan or get a better deal,” he said. He further flagged concerns about PBMs substituting biosimilars with higher-margin alternatives they secretly profit from, calling it a deceptive tactic that employers and manufacturers rarely detect due to lack of access to claims data.
The Trump administration pushed federal agencies to cut drug costs and improve Medicare access. The executive order backed changes to Medicare Part D premiums and aimed to lower prices on high-cost drugs, even those outside the price negotiation plan. It also focused on insulin affordability, Medicaid reform, and opening up safe drug imports to boost competition.
“This is the kind of structural reform we need,” Cuban stressed. “Put me in, coach—I’m here to help.”
Also Read: Gabrielle Union’s stunning summer bikini photoshoot gets applause from Carmelo Anthony’s ex La La Anthony
Cuban extending his support for Trump was surprising, considering the business mogul’s recent comment on the tariffs implemented by the President, as he blamed the decision for potential economic downfall.
Cuban has sold his majority stake in the Dallas Mavericks for an eye-popping $3.5 billion. While stepping back as the main owner, he’s still holding on to a 27% share. Cuban will also continue to have a strong influence on the team.
Apart from his minority ownership in the Mavericks, Cuban cofounded Broadcast.com with fellow Indiana University alum Todd Wagner in 1995, later selling it to Yahoo for $5.7 billion. Another venture includes Cost Plus Drugs, launched in 2022 to make prescription medications more affordable.